A heterostructure for tetracycline degradation and a process of its preparation
Patent Information
- Application Number
- IN202441031918
- Authority / Receiving Office
- IN · IN
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2024-04-22
- Publication Date
- 2026-08-12
- Estimated Expiration
- 2044-04-22
AI Technical Summary
Tetracycline, due to its stable molecular structure and poor biodegradability, is difficult to remove using traditional wastewater treatment methods, and existing advanced oxidative processes and microbial degradation methods are expensive, energy-intensive, and not environmentally friendly, with sonocatalytic and photocatalytic processes lacking efficiency.
A copper-metal organic framework-zinc tungstate (Cu-MOF/ZnWO4) heterostructure integrated with visible light and ultrasonic irradiation for tetracycline degradation, prepared through a process involving the mixing of organic frameworks, copper and zinc precursors, and calcination, providing a stable and efficient degradation solution.
The Cu-MOF/ZnWO4 heterostructure enhances sonophotocatalytic degradation of tetracycline, offering a cost-effective, efficient, and environmentally friendly solution for tetracycline contamination in water bodies, improving water quality and reducing health risks, with stability up to 6 consecutive cycles.
Abstract
Description
FIELDThe present disclosure relates to a heterostructure for tetracycline degradation and a process for its preparation.ACRONYMS:Cu-MOF / ZnWO4: Copper-metal organic framework-zinc tungstate;BTC: Benzene-1,3,5-tricarboxylic acid;Cu-BTC: Copper benzene-1,3,5-tricarboxylic acid; RO water: Water purified by reverse Osmosis.BACKGROUND:The background information herein below relates to the present disclosure but is not necessarily prior art. Tetracycline is a class of broad spectrum antibiotics that prevents the growth and spread of the bacteria. It is used to treat a number of infections, including acne, cholera, brucellosis, plague, malaria, syphilis and the like in human beings. It is also used in veterinary medicines. However, tetracycline has become a serious threat to the environment because of its overuse by humans and veterinarians, weak ability to degrade and its residues remaining in the drinking water. Tetracycline is capable of accumulating along the food chain as well as there is a risk of development of antibiotic resistance and disrupting microbial flora in the human intestine.Tetracycline has stable molecular structure and poor biodegradability due to which it is difficult to remove by traditional wastewater treatment technology such as biological treatment, prechlorination, membrane filtration, adsorption and the like. Other methods such as advanced oxidative processes, ozonation, fenton process, photolysis for tetracycline degradation are expensive, energy-intensive, and not environment friendly. Further, microbial degradation used for degradationof tetracyclines in the soil is expensive. Furthermore, the sonocatalytic and photocatalytic processes for tetracycline degradation lack efficiency.Therefore, there is felt a need to provide a material for tetracycline degradation that mitigates the drawbacks mentioned hereinabove or at least provides a useful alternative.OBJECTS: Some of the objects of the present disclosure, which at least one embodiment herein satisfies, are as follows.An object of the present disclosure to ameliorate one or more problems of background and to provide at least a useful alternative.An object of the present disclosure is to provide a copper-metal organic framework - zinc tungstate (Cu-MOF / ZnWO4) heterostructure.Another object of the present disclosure is to provide a copper-metal organic framework-zinc tungstate (Cu-MOF / ZnWO4) heterostructure for tetracycline degradation.Yet another object of the present disclosure is to provide a copper-metal organic framework-zinc tungstate (Cu-MOF / ZnWO4) heterostructure integrated along with a combination of visible light and ultrasonic irradiation for tetracycline degradation.Still another object of the present disclosure is to provide a process for the preparation of a copper-metal organic framework - zinc tungstate (Cu-MOF / ZnWO4) heterostructure.Yet another object of the present disclosure is to provide a simple and efficient process for the preparation of copper-metal organic framework - zinc tungstate (Cu-MOF / ZnWO4) heterostructure.Still another object of the present disclosure is to provide an industrially scalable process for the preparation of copper-metal organic framework - zinc tungstate (Cu-MOF / ZnWO4) heterostructure.Other objects and advantages of the present disclosure will be more apparent from the following description, which is not intended to limit the scope of the present disclosure. SUMMARYThe present disclosure relates to a copper-metal organic framework - zinc tungstate (Cu-MOF / ZnWO4) heterostructure for tetracycline degradation comprising copper-metal organic framework - zinc tungstate (Cu-MOF / ZnWO4) heterostructure in a molar ratio in the range of 1:1 to 4:1. The heterostructure is integrated along with visible light and ultrasonic irradiation for tetracycline degradation.The organic framework is selected from the group consisting of benzene 1, 3, 5 tricarboxylic acid (BTC), 1,4-benzenedicarboxylic acid, benzophenone-4,4'-dicarboxylate, terephthalic acid, hexaaminobenzene, flavone-6,2'-dicarboxylic acid, 2,4,6-tris(4-pyridyl)-1,3,5-triazine, propargyl carbamate-functionalized isophthalate, triaminotrihydroxybenzene, 1,4-naphthalenedicarboxylic acid, 9,10-anthracenedicarboxylic acid, pyridylcarboxylate, 5,5'-(2,3-dimethylbenzene-1,4-diyl)diisophthalic acid, 4-sulfonaphthalene-2,6-dicarboxylate, triazolyl isophthalate, 4,4',4''-s-triazine-2,4,6-triyl-tribenzoic acid and caffeic acid.Further the present disclosure, relates to a process for the preparation of copper-metal organic framework - zinc tungstate (Cu-MOF / ZnWO4) heterostructure. The process comprises mixing an organic framework in a first fluid medium to obtain a solution of organic framework. Copper precursor is separately mixed in a mixture of water and a second fluid medium to obtain a copper precursor solution. The solution of the organic framework and the copper precursor solution are mixed followed by sonicating at a frequency in the range of 20 kHz to 150 kHz and at a power in the range of 450 to 600 W to obtain a first mixture. The firstmixture is heated at a first predetermined temperature for a first predetermined time period in an autoclave to obtain a reaction mass comprising copper-metal organic framework (Cu-MOF) solids. The copper-metal organic framework (Cu-MOF) solids are separated from the reaction mass followed by washing the solids with a third fluid medium and heating at a second predetermined temperature for a second predetermined time period to obtain copper-metal organic framework (Cu-MOF) crystals. Zinc precursor, tungsten precursor and water are separately mixed to obtain a second mixture. The second mixture is heated at a third predetermined temperature for a third predetermined time period in an autoclave to obtain zinc tungstate (ZnWO4) crystals. The copper-metal organic framework (Cu-MOF) crystals and the zinc tungstate (ZnWO4) crystals are mixed in a predetermined molar ratio in a fourth fluid medium to obtain slurry. The slurry is calcined at a fourth predetermined temperature for a fourth predetermined time period to obtain copper-metal organic framework - zinc tungstate (Cu-MOF / ZnWO4) heterostructure.The organic framework is selected from the group consisting of benzene 1, 3, 5 tricarboxylic acid (BTC), 1,4-benzenedicarboxylic acid, benzophenone-4,4'-dicarboxylate, terephthalic acid, hexaaminobenzene, flavone-6,2'-dicarboxylic acid, 2,4,6-tris(4-pyridyl)-1,3,5-triazine, propargyl carbamate-functionalized isophthalate, triaminotrihydroxybenzene, 1,4-naphthalenedicarboxylic acid, 9,10-anthracenedicarboxylic acid, pyridylcarboxylate, 5,5'-(2,3-dimethylbenzene-1,4-diyl)diisophthalic acid, 4-sulfonaphthalene-2,6-dicarboxylate, triazolyl isophthalate, 4,4',4''-s-triazine-2,4,6-triyl-tribenzoic acid and caffeic acid.The copper precursor is selected from the group consisting of copper nitrate trihydrate (Cu (NO3)2.3H2O), copper chloride dihydrate (CuCl2.2H2O), and copper sulfate pentahydrate (CuSO4·5H2O). The zinc precursor is selected from the group consisting of zinc chloride hexahydrate (ZnCl2.6H2O), zinc nitrate hexahydrate (Zn(NO3)3.6H2O), zinc acetate dihydrate (Zn(CH3COO)2.2H2O) and zinc sulfate heptahydrate (ZnSO4.7H2O).The tungsten precursor is selected from the group consisting of sodium tungstate dihydrate (Na2WO4.2H2O), ammonium tungsten bronze (ATB), ammonium tungstate ((NH4)xWO3) and tungsten hexachloride (WCl6).The molar ratio of the organic framework to the copper precursor is in the range of 1:1 to 1:3.The volume ratio of water and the second fluid medium is in the range of 1:0.5 to 1:2.The molar ratio of the zinc precursor and the tungstate precursor is in the range of 1:0.5 to 1:2.The predetermined molar ratio of the copper-metal organic framework (Cu-MOF) to the zinc tungstate (ZnWO4) is in the range of 1:1 to 4:1. The first fluid medium is selected from the group consisting of ethanol and acetone.The second fluid medium is selected from the group consisting of dimethylformamide (DMF), N, N-dimethylacetamide (DMAc), N-methyl-2-pyrrolidone (NMP), dimethyl sulfoxide (DMSO), acetonitrile and ethylene glycol. The third fluid medium is at least one selected from the group consisting of dimethylformamide, ethanol, acetone methanol and water.The fourth fluid medium is selected from the group consisting of ethanol, acetone, methanol and isopropanol.The first predetermined temperature is in the range of 100 °C to 130 °C. The second predetermined temperature is in the range of 60 °C to 90 °C. The third predetermined temperature is in the range of 150 °C to 200 °C. The fourth predetermined temperature is in the range of 400 °C to 500 °C.The first predetermined time period is in the range of 15 hours to 30 hours. The second predetermined time period is in the range of 5 hours to 15 hours. The thirdpredetermined time period is in the range of 15 hours to 30 hours. The fourth predetermined time period is in the range of 2 hours to 4 hours.BRIEF DESCRIPTION OF THE ACCOMPANYING DRAWINGThe present disclosure will now be described with the help of the accompanying drawing, in which:Figure 1 illustrates tetracycline degradation using visible light and ultrasonic irradiation wherein (a) Cardboard for preventing visible light scattering (b) Ultrasonic bath (Frequency - 40 kHz; Power - 600 W) (c) Light source - Halogen lamp (500 W) (d) RO water (e) Beaker (100 mL) containing TC solution with Cu- metal organic framework zinc tungstate heterostructure;Figure 2 illustrates (a) Probe sonicator [Frequency - 100 kHz; Power - 500 W] used for copper-metal organic framework heterostructure (Cu-MOF) synthesis;Figure 3 illustrates FE-SEM images of (b) copper-metal organic framework (Cu-MOF), (c) ZnWO4, and (d) Cu-MOF / ZnWO4 heterostructure;Figure 4 illustrates HR-TEM images of (e) copper-metal organic framework (Cu-MOF), (f) ZnWO4, and (g) Cu-MOF / ZnWO4 heterostructure; Figure 5 illustrates degradation of tetracycline using sonocatalytic process, photocatalytic process and sonophotocatalytic process using Cu-metal organic framework - zinc tungstate heterostructure (Cu-MOF / ZnWO4 ) heterostructure;Figure 6 illustrates the schematic representation depicting the degradation of tetracycline using sonophotocatalysis on Cu-metal organic framework - zinc tungstate heterostructure (Cu-MOF / ZnWO4);Figure 7 (a) illustrates XRD patterns of Cu-BTC, ZnWO4 and Cu-MOF / ZnWO4 heterostructure;Figure 7 (b) illustrates FTIR spectra of Cu-BTC, ZnWO4 and Cu-MOF / ZnWO4 heterostructure; Figure 8 illustrates sonophotocatalytic tetracycline degradation over Cu-MOF / ZnWO4 heterostructure in different matrices, including RO water, tap water, and hospital effluent; andFigure 9 illustrates sonophotocatalytic degradation of tetracycline employing different ratios of 1:3, 1:1, and 3:1 (copper benzene-1,3,5-tricarboxylic acid) and ZnWO4.DETAILED DESCRIPTIONThe present disclosure relates to a heterostructure for tetracycline degradation and a process for its preparation. Particularly, the present disclosure relates to a copper-metal organic framework - zinc tungstate (Cu-MOF / ZnWO4) heterostructure for tetracycline degradation.Embodiments, of the present disclosure, will now be described with reference to the accompanying drawing.Embodiments are provided so as to thoroughly and fully convey the scope of the present disclosure to the person skilled in the art. Numerous details are set forth, relating to specific components, and methods, to provide a complete understanding of embodiments of the present disclosure. It will be apparent to the person skilled in the art that the details provided in the embodiments should not be construed to limit the scope of the present disclosure. In some embodiments, known processes or well-known apparatus or structures, and well known techniques are not described in detail.The terminology used, in the present disclosure, is only for the purpose of explaining a particular embodiment and such terminology shall not be considered to limit the scope of the present disclosure. As used in the present disclosure, the forms "a," "an," and "the" may be intended to include the plural forms as well, unless the context clearly suggests otherwise. The terms "comprises," "comprising," "including," and "having," are open ended transitional phrases and therefore specify the presence of stated features, integers, steps, operations, elements, modules, units and / or components, but do not forbid the presence or addition of one or more other features, integers, steps, operations, elements, components, and / or groups thereof. The particular order of steps disclosed in the method and process of the present disclosure are not to be construed asnecessarily requiring their performance as described or illustrated. It is also to be understood that additional or alternative steps may be employed.The terms first, second, third, etc., should not be construed to limit the scope of the present disclosure as the aforementioned terms may be only used to distinguish one element, component, region, layer or section from another component, region, layer or section. Terms such as first, second, third etc., when used herein do not imply a specific sequence or order unless clearly suggested by the present disclosure.Tetracycline has stable molecular structure and poor biodegradability due to which it is difficult to be removed by traditional wastewater treatment technology such as biological treatment, prechlorination, membrane filtration, and adsorption. Other methods such as advanced oxidative processes, ozonation, fenton process, photolysis for tetracycline degradation are expensive, energy-intensive, and not environment friendly. Further, microbial degradation used for degradation of tetracyclines in the soil is expensive. Furthermore, the sonocatalytic and photocatalytic processes for tetracycline degradation lack efficiency. Therefore, there is felt a need to provide a material for tetracycline degradation which is economical as well as efficient.The present disclosure provides a copper-metal organic framework - zinc tungstate (Cu-MOF / ZnWO4) heterostructure and a process for its preparation. Copper-metal organic framework - zinc tungstate (Cu-MOF / ZnWO4) heterostructure provides enhanced sonophotocatalytic degradation of tetracycline and is stable.In a first aspect, the present disclosure relates to a copper-metal organic framework - zinc tungstate (Cu-MOF / ZnWO4) heterostructure.The copper-metal organic framework - zinc tungstate (Cu-MOF / ZnWO4) heterostructure for tetracycline degradation comprises copper-metal organic framework (Cu-MOF) and zinc tungstate (ZnWO4) in a molar ratio in the range of 1:1 to 4:1. The copper-metal organic framework-zinc tungstate (Cu-MOF / ZnWO4) heterostructure is integrated along with visible light and ultrasonic irradiation for tetracycline degradation.The organic framework is selected from the group consisting of benzene 1, 3, 5 tricarboxylic acid (BTC), 1,4-benzenedicarboxylic acid, benzophenone-4,4'-dicarboxylate, terephthalic acid, hexaaminobenzene, flavone-6,2'-dicarboxylic acid, 2,4,6-tris(4-pyridyl)-1,3,5-triazine, propargyl carbamate-functionalized isophthalate, triaminotrihydroxybenzene, 1,4-naphthalenedicarboxylic acid, 9,10-anthracenedicarboxylic acid, pyridylcarboxylate, 5,5'-(2,3-dimethylbenzene-1,4-diyl)diisophthalic acid, 4-sulfonaphthalene-2,6-dicarboxylate, triazolyl isophthalate, 4,4',4''-s-triazine-2,4,6-triyl-tribenzoic acid and caffeic acid. In a second aspect, the present disclosure provides a process for the preparation of copper-metal organic framework - zinc tungstate (Cu-MOF / ZnWO4) heterostructure comprising the steps of:i. mixing an organic framework in a first fluid medium to obtain a solution of organic framework.ii. separately mixing a copper precursor in a mixture of water and a second fluid medium to obtain a copper precursor solution;iii. mixing the solution of organic framework and the copper precursor solution and sonicating at a frequency in the range of 20 kHz to 150 kHz and a power in the range of 450 W to 600 W to obtain a first mixture;iv. heating the first mixture at a first predetermined temperature for a first predetermined time period in an autoclave to obtain a reaction mass comprising copper-metal organic framework (Cu-MOF) solids;v. separating the copper-metal organic framework (Cu-MOF) solids from the reaction mass followed by washing the solids with a third fluid medium and heating at a second predetermined temperature for a second predetermined time period to obtain copper-metal organic framework (Cu-MOF) crystals;vi. separately mixing zinc precursor, tungsten precursor and water to obtain a second mixture;vii. heating the second mixture at a third predetermined temperature for a third predetermined time period in an autoclave to obtain zinc tungstate (ZnWO4) crystals;viii. mixing the Cu-MOF crystals and the zinc tungstate (ZnWO4) crystals in a predetermined molar ratio in a fourth fluid medium to obtain a slurry; andix. calcining the slurry at a fourth predetermined temperature for a fourth predetermined time period to obtain copper-metal organic framework - zinc tungstate (Cu-MOF / ZnWO4) heterostructure. The process for the preparation of Cu-MOF / ZnWO4 heterostructure is detailed below:In a first step, an organic framework is mixed in a first fluid medium to obtain a solution of organic framework.The first fluid medium is selected from the group consisting of ethanol and acetone. In an exemplary embodiment of the present disclosure, the first fluid medium is ethanol.In a second step, a copper precursor is mixed in a mixture of second fluid medium and water to obtain a copper precursor solution. The copper precursor is selected from the group consisting of copper nitrate trihydrate (Cu(NO3)2.3H2O), copper chloride dihydrate (CuCl2.2H2O) and copper sulfate pentahydrate (CuSO4·5H2O).The second fluid medium is selected from the group consisting of dimethylformamide (DMF), N,N-dimethylacetamide (DMAc), N-methyl-2-pyrrolidone (NMP), dimethyl sulfoxide (DMSO), acetonitrile and ethylene glycol. In an exemplary embodiment of the present disclosure, the second fluid medium is dimethylformamide (DMF).The molar ratio of organic framework and copper precursor is in the range of 1:1 to 1:3. In an exemplary embodiment of the present disclosure, the molar ratio of organic framework and copper precursor is 1:2.The volume ratio of water and second fluid medium is in the range of 1:0.5 to 1:2. In an exemplary embodiment of the present disclosure, the volume ratio of water and second fluid medium is 1:1.In a third step, the solution of organic framework and copper precursor solution are mixed followed by sonication at a frequency in the range of 20 kHz to 150 kHz and power in the range of 450 W to 600 W to obtain a first mixture. In an exemplary embodiment of the present disclosure, the solution of organic framework and the copper precursor solution are mixed followed by probe sonication at a frequency of 100 kHz and power of 500 W to obtain a first mixture.In a fourth step, the first mixture is heated at a first predetermined temperature for a first predetermined time period in an autoclave to obtain a reaction mass comprising copper-metal organic framework (Cu-MOF) solids.The first predetermined temperature is in the range of 100 °C to 130 °C. In an exemplary embodiment of the present disclosure, the first predetermined temperature is 120 °C.The first predetermined time period is in the range of 15 hours to 30 hours. In an exemplary embodiment of the present disclosure, the first predetermined time period is 24 hours.In a fifth step, copper-metal organic framework (Cu-MOF) solids are separated from the reaction mass followed by washing the solids with a third fluid medium and is heated at a second predetermined temperature for a second predetermined time period to obtain copper-metal organic framework (Cu-MOF) crystals.The third fluid medium is at least one selected from the group consisting of dimethylformamide, ethanol, acetone, methanol and water. In an exemplary embodiment, the third fluid medium is dimethyl formamide and ethanol in the range of 1:1.The second predetermined temperature is in the range of 60 °C to 90 °C. In an exemplary embodiment of the present disclosure, the second predetermined temperature is 70°C.The second predetermined time period is in the range of 5 hours to 15 hours. In an exemplary embodiment of the present disclosure, the second predetermined time period is 8 hours. In a sixth step, zinc precursor, tungstate precursor and water are separately mixed to obtain a second mixture.The zinc precursor is selected from the group consisting of zinc chloride hexahydrate (ZnCl2.6H2O), zinc nitrate hexahydrate (Zn(NO3)3.6H2O), zinc acetate dihydrate (Zn(CH3COO)2.2H2O) and zinc sulfate heptahydrate (ZnSO4.7H2O). The tungsten precursor is selected from the group consisting of sodium tungstate dihydrate (Na2WO4.2H2O), ammonium tungsten bronze (ATB), ammonium tungstate ((NH4)xWO3) and tungsten hexachloride (WCl6).The molar ratio of zinc precursor and tungsten precursor is in the range of 1:0.5 to 1:2. In an exemplary embodiment of the present disclosure, the molar ratio of zinc chloride and sodium tungstate is 1:1.In a seventh step, the second mixture is heated in an autoclave at a third predetermined temperature for a third predetermined time period in an autoclave to obtain zinc tungstate (ZnWO4) crystals.The third predetermined temperature is in the range of 150 °C to 200 °C. In an exemplary embodiment of the present disclosure, the third predetermined temperature is 180 °C.The third predetermined time period is in the range of 15 hours to 30 hours. In an exemplary embodiment of the present disclosure, the third predetermined time period is 24 hours.In an eighth step, the copper-metal organic framework (Cu-MOF) crystals and zinc tungstate (ZnWO4) crystals are mixed in a predetermined molar ratio in a fourth fluid medium to obtain a slurry.The predetermined molar ratio of copper-metal organic framework (Cu-MOF) to zinc tungstate (ZnWO4) is in the range of 1:1 to 4:1. In an exemplary embodiment of the present disclosure, the molar ratio of copper-metal organic framework (Cu-MOF) to zinc tungstate (ZnWO4) is 3:1.The fourth fluid medium is selected from the group consisting of ethanol, acetone, methanol and isopropanol. In an exemplary embodiment of the present disclosure, the fourth fluid medium is ethanol. In a ninth step, the slurry is calcined at a fourth predetermined temperature for a fourth predetermined time period to obtain copper-metal organic framework - zinc tungstate (Cu-MOF / ZnWO4) heterostructure.The fourth predetermined temperature is in the range of 400 °C to 500 °C. In an exemplary embodiment of the present disclosure, the fourth predetermined temperature is 450°C.The fourth predetermined time period is in the range of 2 hours to 4 hours. In an exemplary embodiment of the present disclosure, the fourth predetermined time period is 3 hours.Copper-metal organic framework - zinc tungstate (Cu-MOF / ZnWO4) heterostructure of the present disclosure provides enhanced sonophotocatalytic degradation of tetracycline compared to the conventional materials used for tetracycline degradation.In accordance with the present disclosure, ultrasound-assisted hydrothermal treatment in the process of preparation of copper-metal organic framework - zinc tungstate (Cu-MOF / ZnWO4) heterostructure provides enhanced efficiency and effectiveness of copper-metal organic framework - zinc tungstate (Cu-MOF / ZnWO4) heterostructure.In accordance with the present disclosure, the mixing of copper-metal organic framework (Cu-MOF) and zinc tungstate (ZnWO4) in a molar ratio in the range of 1:1 to 4:1 and calcination step in the process of preparation of copper-metal organic framework (Cu-MOF) and zinc tungstate (ZnWO4) provide copper-metal organic framework (Cu-MOF) - zinc tungstate (Cu-MOF / ZnWO4) heterostructure with improved performance. The combination of visible light and ultrasonic irradiation along with copper- metal organic framework (Cu-MOF) - zinc tungstate (Cu-MOF / ZnWO4) heterostructure can effectively degrade tetracycline as compared to the traditional photocatalytic or sonocatalytic methods. The combined effect of visible light and ultrasonic irradiation enhances the degradation efficiency of tetracycline thereby providing an effective solution for tetracycline contamination in water bodies, thereby improving water quality and reducing the health risks associated with tetracycline contamination. Figure 5 illustrates degradation of tetracycline using sonocatalytic process, photocatalytic process and sonophotocatalytic process using copper-metal organic framework - zinc tungstate (Cu-MOF / ZnWO4) heterostructure of the present disclosure.Copper-metal organic framework-zinc tungstate (Cu-MOF / ZnWO4) heterostructure of the present disclosure is incorporated in the waste water treatment processes of industries carrying out the production of tetracycline which aid in complying with environmental regulations and reduce the environmental impact of their operations.The copper-metal organic framework - zinc tungstate (Cu-MOF / ZnWO4) heterostructure is employed to degrade tetracycline in contaminated soils or water bodies, helping to mitigate the environmental impact of tetracycline pollution. This application is beneficial in areas where tetracycline contamination isprevalent, such as regions with intensive agricultural activities or areas with inadequate wastewater treatment facilities.In accordance with the present disclosure, copper-metal organic framework - zinc tungstate (Cu-MOF / ZnWO4) heterostructure is integrated along with visible light and ultrasonic irradiation for tetracycline degradation. The degradation efficiency is determined by monitoring the concentration of residual tetracycline over time. The trapping agents are used to investigate the reactive species involved in the degradation process which provides a deeper understanding of the underlying mechanisms. This aids in optimizing the process, minimize unwanted by-products and enhance the overall efficiency of tetracycline degradation.In accordance with the present disclosure, copper-metal organic framework - zinc tungstate (Cu-MOF / ZnWO4) heterostructure is highly stable, durable and can be reused. Copper-metal organic framework - zinc tungstate (Cu-MOF / ZnWO4) heterostructure is stable upto 6 consecutive cycles. The stability of copper-metal organic framework - zinc tungstate (Cu-MOF / ZnWO4) heterostructure is evaluated by XRD and FTIR analysis. The foregoing description of the embodiments has been provided for purposes of illustration and not intended to limit the scope of the present disclosure. Individual components of a particular embodiment are generally not limited to that particular embodiment, but, are interchangeable. Such variations are not to be regarded as a departure from the present disclosure, and all such modifications are considered to be within the scope of the present disclosure.The present disclosure is further described in light of the following experiments which are set forth for illustration purposes only and not to be construed for limiting the scope of the disclosure. The following experiments can be scaled upto industrial / commercial scale and the results obtained can be extrapolated to industrial scale. EXPERIMENTAL DETAILSExperiment 1: Procedure for the preparation of Cu-MOF / ZnWO4 (copper benzene-1, 3, 5-tricarboxylic acid / ZnWO4) heterostructure:Step-i - Process for the preparation of copper-metal organic framework (copper benzene-1, 3, 5-tricarboxylic acid)4.91 g (23.4 mmol) benzene-1, 3, 5-tricarboxylic acid was dissolved in 40 ml ethanol to obtain a solution of benzene 1, 3, 5 tricarboxylic acid. Separately 10.86 g (46.6 mmol) copper nitrate trihydrate was mixed in a mixture of 25 ml dimethylformamide and 25 ml deionized water (ratio of dimethylformamide: deionized water is 1:1) to obtain copper nitrate solution. Benzene 1, 3, 5 tricarboxylic acid solution and copper nitrate trihydrate solution were thoroughly mixed on a magnetic stirrer and then subjected to probe sonication with a frequency of 100 kHz and a power of 500 W to obtain a first mixture. Figure 2 illustrates probe sonicator used for Cu-BTC synthesis. The first mixture was transferred into an autoclave for hydrothermal treatment at 120°C for 24 hours to obtain a reaction mass comprising copper-metal organic framework (Cu-MOF) solids. The mother liquor was decanted from the reaction mass and copper-metal organic framework (Cu-MOF) solids were separated and washed with 50 ml dimethylformamide and 50 ml ethanol. The copper-metal organic framework (Cu-MOF) solids were then heat-treated under vacuum at 70 °C for 8 hours to obtain copper benzene-1, 3, 5-tricarboxylic acid (copper-metal organic framework (Cu-MOF)) crystals.Step ii- Process for the preparation of zinc tungstate (ZnWO4)ZnWO4 was synthesized using a hydrothermal method. 0.0244 g (4 mmol) zinc chloride hexahydrate, 0.0329 g (4 mmol) sodium tungstate dihydrate and 20 ml deionized water were mixed into 25 ml autoclave vessel to obtain a second mixture. The second mixture was heated to 180 °C for 24 hours to obtain zinc tungstate (ZnWO4) crystals.Step iii-Process for the preparation of copper-metal organic framework - zinc tungstate (Cu-MOF / ZnWO4) heterostructure (copper-(benzene-1,3,5-tricarboxylic acid) / ZnWO4 heterostructure)3 g of copper benzene-1,3,5-tricarboxylic acid , 1 g of ZnWO4 (molar ratio of Cu-BTC and ZnWO4 was 3:1) and 5 ml of ethanol were mixed to obtain a slurry. The obtained slurry was calcined at 450 °C for 3 hours to obtain copper-metal organicframework - zinc tungstate (Cu-MOF / ZnWO4) heterostructure (copper-(benzene-1,3,5-tricarboxylic acid) / ZnWO4 heterostructure).Figure 1 illustrates preparation of Cu-MOF / ZnWO4 (copper benzene-1, 3, 5-tricarboxylic acid / ZnWO4) heterostructure in accordance with the present disclosureFigure 6 illustrates the schematic representation depicting the degradation of tetracycline using sonophotocatalysis on Cu- metal organic framework zinc tungstate heterostructure (Cu-MOF / ZnWO4) photocatalyst.Figure 3 illustrates FE-SEM images of (b) copper-metal organic framework heterostructure (Cu-MOF), (c) ZnWO4 and (d) Cu-MOF / ZnWO4 heterostructure carried out on JEOL JSM-7100F129eV with resolution silicon drift detector (SDD).Figure 7 (a) illustrates XRD patterns of Cu-BTC, ZnWO4 and Cu-MOF / ZnWO4 heterostructure.Figure 7 (b) illustrates FTIR spectra of Cu-BTC, ZnWO4 and Cu-MOF / ZnWO4 heterostructure.Experiment 2: Process for sonophotocatalytic tetracycline degradation using (copper-(benzene-1,3,5-tricarboxylic acid) / ZnWO4 heterostructure) prepared in accordance with the present disclosure The optimised heterostructure was agitated for 60 min to reach adsorption-desorption equilibrium. About 40 mL of 20 ppm TC solution was used for each experiment with 20 mg (copper-(benzene-1,3,5-tricarboxylic acid) / ZnWO4 heterostructure (photocatalyst). The photochemical reactor made of quartz was constructed in a cylindrical shape, with dimensions of 45 cm in height and 6 cm in diameter. A water circulation system was included into the reactor to control and maintain a temperature of 25±5 °C. The developed heterostructure was tested under visible-light irradiation from a 500 W halogen lamp and ultrasonic irradiation at 40 kHz and 600 W using a bath-type ultrasonicator. The (copper-(benzene-1,3,5-tricarboxylic acid) / ZnWO4 heterostructure (catalyst) was recovered using centrifugation at 15-minute intervals, and the changes in TCconcentration were evaluated using a UV-Vis absorption spectrophotometer. An experiment was conducted to examine the efficiency of sonophotocatalysis, sonocatalysis, and photocatalysis. Each step was continued for 60 minutes. The Figure 5 depicts the degradation of TC using sonocatalysis (ultrasound+catalyst), photocatalysis (visible light + catalyst), and sonophotocatalysis (visible light+ultrasound+catalyst). From figure 5, it was seen that enhanced degradation of tetracycline was observed by sonophotocatalysis using Cu-BTC / ZnWO4 heterostructure of the present disclosure.Experiment 3: Analysis of tetracycline degradation in different water matrices using Cu-BTC / ZnWO4 heterostructure of the present disclosureWater samples were collected from three different sources i.e., distilled water (RO water), tap water and hospital effluent. Using these water samples, three different Tetracycline (TC) solutions were prepared by dissolving an equal amount of TC in each of water sample.20ppm (20mg / L) TC solution for each sample was prepared by separately dissolving 2mg of TC in 100 mL of RO water, 2mg in 100 mL of tap water and 2mg in 100 mL of hospital effluent.The characteristics of water quality parameters for RO water, tap water and hospital effluent was analysed by physical examination and chemical examination. The results of examination studies were provided in table 1. It was observed that there was an increased efficiency of TC degradation in RO water when compared to the tap water and the hospital effluent.RO water was found more efficient than tap water and hospital effluent because RO water was subjected to thorough filtering procedures, which eliminate pollutants, contaminants and minerals, creating an optimal setting for chemical reactions, such as degradation processes.Additionally, tap water often includes chlorine or chloramine chemicals that are intentionally added to sterilise it. These compounds may disrupt chemical processes, such as degradation. On the other hand, RO water usually eliminatesthese substances during the filtering process, hence decreasing the likelihood of any disruption.Additionally, the hospital wastewater may include organic chemicals from other origins, which might interact with tetracycline molecules and decrease the efficacy of breakdown.Due to its thorough filtering process, RO water was free from organic pollutants, which enables more effective breakdown. Furthermore, RO water systems were specifically engineered to consistently provide water of high quality, with carefully regulated pH levels and ionic strength. This ensures that optimal conditions were maintained for the gradual breakdown of tetracycline over a period of time. The combination of these elements contributes to the higher efficiency of tetracycline breakdown in RO water as compared to the tap water and the hospital effluent. Figure 8 shows that the sonophotocatalytic degradation of TC with RO water using Cu-BTC / ZnWO4 heterostructure of the present disclosure was 76%. In contrast, degradation using Cu-BTC / ZnWO4 heterostructure of the present disclosure was less effective in tap water (52%) and hospital effluent (44%), likely due to additional contaminants in the real water samples. To investigate the impact of different water matrices on the sonophotocatalytic performance of Cu-MOF / ZnWO4 of the present disclosure, various water samples including RO water, tap water and real water samples from hospital effluent were collected and evaluated for tetracycline degradation. The characteristics of different matrices are detailed in Table 1 below.Table 1. Characteristics of water quality parameters for RO water, tap water, and hospital effluentFigure 8 illustrates sonophotocatalytic TC degradation over Cu-MOF / ZnWO4 heterostructure in different matrices, including RO water, tap water and hospital effluent.Experiment 4: Comparative study The same procedure was carried out as in experiment 1 for the preparation of copper benzene-1, 3, 5-tricarboxylic acid / ZnWO4 heterostructure by varying the ratio of copper benzene-1, 3, 5-tricarboxylic acid and ZnWO4 as 1:3, and 1:1, instead of 3:1.Figure 9 illustrates sonophotocatalytic degradation of TC employing different ratios of 1:3, 1:1, and 3:1 (copper benzene-1,3,5-tricarboxylic acid) and ZnWO4.From figure 9 it can be seen that enhanced degradation of tetracycline was achieved by using copper benzene-1,3,5-tricarboxylic acid and ZnWO4 in the ratio of 3:1.TECHNICAL ADVANCEMENTSThe present disclosure described herein above has several technical advantages including, but not limited to, the realization of- A copper-metal organic framework - zinc tungstate (Cu-MOF / ZnWO4) heterostructure that- is economical;- is stable, durable and reusable; and - provides enhanced degradation efficiency of tetracycline;- A process for the preparation of copper-metal organic framework - zinc tungstate (Cu-MOF / ZnWO4) heterostructure that- is simple, efficient, economical and environment friendly; The embodiments herein and the various features and advantageous details thereof are explained with reference to the non-limiting embodiments in the following description. Descriptions of well-known components and processing techniques are omitted so as to not unnecessarily obscure the embodiments herein. The examples used herein are intended merely to facilitate an understanding of ways in which the embodiments herein may be practiced and to further enable those of skill in the art to practice the embodiments herein. Accordingly, the examples should not be construed as limiting the scope of the embodiments herein. The foregoing description of the specific embodiments so fully reveal the general nature of the embodiments herein that others can, by applying current knowledge, readily modify and / or adapt for various applications such specific embodiments without departing from the generic concept, and, therefore, such adaptations and modifications should and are intended to be comprehended within the meaning and range of equivalents of the disclosed embodiments. It is to be understood that the phraseology or terminology employed herein is for the purpose of descriptionand not of limitation. Therefore, while the embodiments herein have been described in terms of preferred embodiments, those skilled in the art will recognize that the embodiments herein can be practiced with modification within the spirit and scope of the embodiments as described herein. The use of the expression "at least" or "at least one" suggests the use of one or more elements or ingredients or quantities, as the use may be in the embodiment of the disclosure to achieve one or more of the desired objects or results. Any discussion of documents, acts, materials, devices, articles or the like that has been included in this specification is solely for the purpose of providing a context for the disclosure. It is not to be taken as an admission that any or all of these matters form a part of the prior art base or were common general knowledge in the field relevant to the disclosure as it existed anywhere before the priority date of this application. The numerical values mentioned for the various physical parameters, dimensions or quantities are only approximations and it is envisaged that the values higher / lower than the numerical values assigned to the parameters, dimensions or quantities fall within the scope of the disclosure, unless there is a statement in the specification specific to the contrary. While considerable emphasis has been placed herein on the components and component parts of the preferred embodiments, it will be appreciated that many embodiments can be made and that many changes can be made in the preferred embodiments without departing from the principles of the disclosure. These and other changes in the preferred embodiment as well as other embodiments of the disclosure will be apparent to those skilled in the art from the disclosure herein, whereby it is to be distinctly understood that the foregoing descriptive matter is to be interpreted merely as illustrative of the disclosure and not as a limitation.
Claims
1. A copper-metal organic framework - zinc tungstate (Cu-MOF / ZnWO4) heterostructure for tetracycline degradation comprising copper-metal organic framework (Cu-MOF) and zinc tungstate (ZnWO4) in a molar ratio in the range of 1:1 to 4:1.
2. The heterostructure as claimed in claim 1 is integrated along with visible light and ultrasonic irradiation for tetracycline degradation.
3. The heterostructure as claimed in claim 1, wherein said organic framework is selected from the group consisting of benzene 1, 3, 5 tricarboxylic acid (BTC), 1,4-benzenedicarboxylic acid, benzophenone-4,4'-dicarboxylate, terephthalic acid, hexaaminobenzene, flavone-6,2'-dicarboxylic acid, 2,4,6-tris(4-pyridyl)-1,3,5-triazine, propargyl carbamate-functionalized isophthalate, triaminotrihydroxybenzene, 1,4-naphthalenedicarboxylic acid, 9,10-anthracenedicarboxylic acid, pyridylcarboxylate, 5,5'-(2,3-dimethylbenzene-1,4-diyl)diisophthalic acid, 4-sulfonaphthalene-2,6-dicarboxylate, triazolyl isophthalate, 4,4',4''-s-triazine-2,4,6-triyl-tribenzoic acid and caffeic acid.
4. A process for the preparation of copper-metal organic framework - zinc tungstate (Cu-MOF / ZnWO4) heterostructure, said process comprising the following steps: i. mixing an organic framework in a first fluid medium to obtain a solution of organic framework ; ii. separately mixing a copper precursor in a mixture of water and a second fluid medium to obtain a copper precursor solution; iii. mixing said solution of organic framework and said copper precursor solution and sonicating at a frequency in the range of 20 kHz to 150 kHz and at a power in the range of 450 W to 600 W to obtain a first mixture; iv. heating said first mixture at a first predetermined temperature for a first predetermined time period in an autoclave to obtain a reaction mass comprising copper-metal organic framework (Cu-MOF) solids; v. separating said copper-metal organic framework (Cu-MOF) solids from said reaction mass followed by washing said solids with a third fluid medium and heating at a second predetermined temperature for a second predetermined time period to obtain copper-metal organic framework (Cu-MOF) crystals; vi. separately mixing zinc precursor, tungsten precursor and water to obtain a second mixture; vii. heating said second mixture at a third predetermined temperature for a third predetermined time period in an autoclave to obtain zinc tungstate (ZnWO4) crystals; viii. mixing said copper-metal organic framework (Cu-MOF) crystals and said zinc tungstate (ZnWO4) crystals in a predetermined molar ratio in a fourth fluid medium to obtain a slurry; and ix. calcining said slurry at a fourth predetermined temperature for a fourth predetermined time period to obtain said copper-metal organic framework - zinc tungstate (Cu-MOF / ZnWO4) heterostructure.
5. The process as claimed in claim 4, wherein, - said organic framework is selected from the group consisting of benzene 1, 3, 5 tricarboxylic acid (BTC), 1,4-benzenedicarboxylic acid, benzophenone-4,4'-dicarboxylate, terephthalic acid, hexaaminobenzene, flavone-6,2'-dicarboxylic acid, 2,4,6-tris(4-pyridyl)-1,3,5-triazine, propargyl carbamate-functionalized isophthalate, triaminotrihydroxybenzene, 1,4-naphthalenedicarboxylic acid, 9,10-anthracenedicarboxylic acid, pyridylcarboxylate, 5,5'-(2,3-dimethylbenzene-1,4-diyl)diisophthalic acid, 4-sulfonaphthalene-2,6-dicarboxylate, triazolyl isophthalate, 4,4',4''-s-triazine-2,4,6-triyl-tribenzoic acid and caffeic acid. - said copper precursor is selected from the group consisting of copper nitrate trihydrate (Cu(NO3)2.3H2O), copper chloride dihydrate (CuCl2.2H2O) and copper sulfate pentahydrate (CuSO4·5H2O); - said zinc precursor is selected from the group consisting of zinc chloride hexahydrate (ZnCl2.6H2O), zinc nitrate hexahydrate (Zn(NO3)3.6H2O), zinc acetate dihydrate (Zn(CH3COO)2.2H2O) and zinc sulfate heptahydrate (ZnSO4.7H2O); and - said tungsten precursor is selected from the group consisting of sodium tungstate dihydrate (Na2WO4.2H2O), ammonium tungsten bronze (ATB), ammonium tungstate (NH4)xWO3) and tungsten hexachloride (WCl6).
6. The process as claimed in claim 4, wherein - the molar ratio of organic framework to copper precursor is in the range of 1:1 to 1:3; - the volume ratio of water to said second fluid medium is in the range of 1:0.5 to 1:2; and - the molar ratio of zinc precursor to tungstate precursor is in the range of 1:0.5 to 1:2.
7. The process as claimed in claim 4, wherein said predetermined molar ratio of copper-metal organic framework to zinc tungstate (Cu-MOF / ZnWO4) is in the range of 1:1 to 4:1.
8. The process as claimed in claim 4, wherein - said first fluid medium is selected from the group consisting of ethanol and acetone; - said second fluid medium is selected from the group consisting of dimethylformamide (DMF), N,N-dimethylacetamide (DMAc), N- methyl-2-pyrrolidone (NMP), dimethyl sulfoxide (DMSO), acetonitrile and ethylene glycol; - said third fluid medium is at least one selected from the group consisting of dimethylformamide, ethanol, acetone, methanol and water. - said fourth fluid medium is selected from the group consisting of ethanol, acetone, methanol and isopropanol.
9. The process as claimed in claim 4, wherein - said first predetermined temperature is in the range of 100 °C to 130 °C; - said second predetermined temperature is in the range of 60 °C to 90 °C; - said third predetermined temperature is in the range of 150 °C to 200 °C; and - said fourth predetermined temperature is in the range of 400 °C to 500 °C.
10. The process as claimed in claim 4, wherein - said first predetermined time period is in the range of 15 hours to 30 hours; - said second predetermined time period is in the range of 5 hours to 15 hours; - said third predetermined time period is in the range of 15 hours to 30 hours; and - said fourth predetermined time period is in the range of 2 hours to 4 hours.
